Monitoring Levetiracetam in Pregnancy Needs Standardized Guidelines
Researchers studied how levetiracetam, a common medication for epilepsy, is monitored during pregnancy.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
Researchers studied how levetiracetam, a common medication for epilepsy, is monitored during pregnancy.
This study looked at a specific genetic cause of focal epilepsy called DEPDC5 variants, which are often linked to brain abnormalities.
Researchers studied a specific genetic change in the NBEA gene in a child from China who had developmental delays and epilepsy.
This study looked at a group of Japanese patients with specific genetic changes known as DHDDS variants, which are linked to severe epilepsy and movement disorders.
Researchers studied the use of a medication called perampanel, which is already approved for treating seizures in epilepsy, to see if it could help people with severe tremors.
This study looked at Tuberous Sclerosis Complex (TSC), a rare genetic disorder, in Greece.
A study was conducted in Jordan to understand how well pediatricians and pediatric residents know about epilepsy and its management.
A study was conducted to evaluate how effective a medication called cenobamate is for adults with uncontrolled focal epilepsy.
Researchers studied three children diagnosed with DEND syndrome, which includes developmental delay, epilepsy, and neonatal diabetes.